Previous studies have been reported that NRG1 played important roles in cancers by directly binding to ERBB3 or ERBB4 and ERBB3 or ERBB4 interacts with ERBB2 or ligand-receptor, leading to receptor phosphorylation and signal cascade activation [21]. Here, ERBB3 is linked to cancer.